The Affiliated Hospital of Qingdao University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

4 drugs in development

Approved3

Phase 31

Phase 21

Phase 12

By Therapeutic Area

top 1

Oncology

583%

R&D Momentum

55/100

Pipeline Velocity

25/100

Trial Completion Rate

100/100

Pipeline Concentration

72/100

Pipeline Freshness

65/100

Activity

Recent Activity

Last 14 days

Jul 2, 2026

Completed

Bioequivalence Study of Two Formulations of a Sitagliptin/Metformin Hydrochloride Extended-Release Tablet in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open-Label, Single-Dose, Crossover Trial

Jul 1, 2026

Active, not recruiting

A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of RFUS-949 Tablets in Healthy Chinese Participants

Earlier

May 1, 2026TrialA Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer

Mar 25, 2026TrialBioavailability of Curcumin Capsules in Healthy Adult Subjects: an Open, Randomized, Single-dose, Two-period, Two-sequence Crossover Study

Feb 28, 2026TrialStudy on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss

Oct 31, 2025TrialThe Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

Oct 31, 2025TrialThe Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma

Jun 1, 2025TrialNeoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

3 more events

Jan 2, 2025TrialA Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects

Dec 4, 2024TrialStudy on Human Bioequivalence of Triprerelin Acetate for Injection

Jun 1, 2024TrialA Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Details